Neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma: Data from literature review and a real‐world analysis
Article in Thoracic Cancer (March 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Clinical study of camrelizumab combined with docetaxel and carboplatin as a neoadjuvant treatment for locally advanced oesophageal squamous cell carcinoma
Article in Diseases of the Esophagus (January 2024)
Lymph node ratio is a prognostic indicator for locally advanced esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy
Article in Biomolecules and Biomedicine (August 2023)